PleuraFlow ACT Commercialization & ERAS Integration
Prevention of Retained Blood Syndrome and complications post-cardiac/thoracic surgery
CommercialActive
Key Facts
Indication
Prevention of Retained Blood Syndrome and complications post-cardiac/thoracic surgery
Phase
Commercial
Status
Active
Company
About ClearFlow
ClearFlow is a private medical device company targeting complications in post-cardiac surgery recovery, primarily Retained Blood Syndrome (RBS). Its core technology, PleuraFlow, is a commercially available active chest tube clearance system clinically demonstrated to reduce RBS, postoperative atrial fibrillation, and ICU length of stay. Led by a seasoned executive team with clinical and commercial expertise, the company is focused on driving adoption in cardiac surgery centers through clinical evidence and integration into Enhanced Recovery After Surgery (ERAS) protocols.
View full company profile